Advanced Solid Malignancies Completed Phase 1 Trials for Zibotentan (DB06629)

Also known as: Advanced Solid Malignancy

IndicationStatusPhase
DBCOND0034803 (Advanced Solid Malignancies)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT0099794510mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid MalignanciesBasic Science